Aducanumab: A Deep Dive into BIIB037 and its Impact The drug, initially known as BIIB037, is a notable endeavor to combat mild Alzheimer's illness. Developed by Biogen, this molecule works by clearing amyloid deposits https://kobigeil300332.activoblog.com/52570933/text